Molecules filgotinib to maribavir
100 molecules with a full cross-agency decision record, part of 534 published in total.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| filgotinib | 26 | 13 | Immunosuppressants |
| filgrastim | 27 | 6 | Immunostimulants |
| finerenone | 21 | 11 | Renin-angiotensin system |
| fingolimod | 30 | 12 | Immunosuppressants |
| fluticasone | 31 | 8 | Nasal preparations |
| fluticasone / formoterol | 8 | 3 | Nasal preparations |
| follitropin alfa | 13 | 5 | Sex hormones and modulators |
| follitropin delta | 7 | 6 | Sex hormones and modulators |
| fondaparinux | 21 | 4 | Antithrombotics |
| fostamatinib | 8 | 8 | Antihemorrhagics |
| fremanezumab | 20 | 13 | Analgesics |
| fruquintinib | 14 | 13 | Antineoplastics |
| fulvestrant | 19 | 7 | Endocrine therapy |
| futibatinib | 11 | 9 | Antineoplastics |
| galcanezumab | 21 | 13 | Analgesics |
| garadacimab | 10 | 10 | Other hematological agents |
| gefitinib | 11 | 7 | Antineoplastics |
| gemcitabine | 17 | 5 | Antineoplastics |
| gemtuzumab ozogamicin | 11 | 10 | Antineoplastics |
| gilteritinib | 18 | 13 | Antineoplastics |
| givosiran | 15 | 12 | Other alimentary tract and metabolism |
| glasdegib | 7 | 6 | Antineoplastics |
| glecaprevir / pibrentasvir | 20 | 10 | Antivirals |
| glofitamab | 26 | 13 | Antineoplastics |
| glucose | 58 | 7 | Blood substitutes and perfusion |
| glycopyrronium | 22 | 8 | Obstructive airway diseases |
| golimumab | 43 | 10 | Immunosuppressants |
| guanfacine | 11 | 7 | Antihypertensives |
| guselkumab | 56 | 13 | Immunosuppressants |
| human normal immunoglobulin | 14 | 3 | Immune sera and immunoglobulins |
| hydrocortisone | 32 | 10 | Systemic corticosteroids |
| hydroxycarbamide | 10 | 4 | Antineoplastics |
| ibrutinib | 108 | 15 | Antineoplastics |
| icatibant | 12 | 7 | Other hematological agents |
| icosapent ethyl | 8 | 7 | Lipid modifying agents |
| idebenone | 16 | 9 | Psychoanaleptics |
| idecabtagene vicleucel | 16 | 9 | Antineoplastics |
| idelalisib | 30 | 8 | Antineoplastics |
| iloprost | 10 | 5 | Antithrombotics |
| imatinib | 30 | 6 | Antineoplastics |
| imiquimod | 16 | 5 | Dermatological anti-infectives |
| inclisiran | 18 | 11 | Lipid modifying agents |
| indacaterol | 8 | 6 | Obstructive airway diseases |
| inebilizumab | 11 | 10 | Immunosuppressants |
| infliximab | 69 | 9 | Immunosuppressants |
| influenza vaccine | 14 | 2 | Vaccines |
| inotersen | 7 | 6 | Other nervous system |
| inotuzumab ozogamicin | 12 | 10 | Antineoplastics |
| insulin degludec | 14 | 7 | Diabetes |
| insulin detemir | 19 | 6 | Diabetes |
| insulin glargine | 26 | 6 | Diabetes |
| insulin glulisine | 7 | 4 | Diabetes |
| insulin lispro | 9 | 5 | Diabetes |
| interferon beta-1a | 15 | 4 | Immunostimulants |
| ipilimumab | 58 | 14 | Antineoplastics |
| ipilimumab / nivolumab | 15 | 6 | Antineoplastics |
| iptacopan | 24 | 12 | Immunosuppressants |
| irinotecan | 18 | 4 | Antineoplastics |
| isatuximab | 38 | 12 | Antineoplastics |
| isavuconazole | 11 | 8 | Antimycotics |
| ivabradine | 18 | 8 | Cardiac therapy |
| ivacaftor | 79 | 12 | Other respiratory |
| ivacaftor / lumacaftor | 25 | 11 | Other respiratory |
| ivacaftor / tezacaftor | 15 | 7 | Other respiratory |
| ivosidenib | 21 | 12 | Antineoplastics |
| ixazomib | 14 | 10 | Antineoplastics |
| ixekizumab | 41 | 11 | Immunosuppressants |
| lacosamide | 22 | 7 | Antiepileptics |
| lanadelumab | 23 | 15 | Other hematological agents |
| lanreotide | 20 | 7 | Pituitary and hypothalamic hormones |
| lapatinib | 10 | 5 | Antineoplastics |
| larotrectinib | 29 | 14 | Antineoplastics |
| latanoprost | 17 | 4 | Ophthalmologicals |
| latanoprost / netarsudil | 7 | 7 | Ophthalmologicals |
| latanoprost / timolol | 9 | 3 | Ophthalmologicals |
| lebrikizumab | 15 | 13 | Other dermatologicals |
| lecanemab | 8 | 8 | Psychoanaleptics |
| ledipasvir / sofosbuvir | 17 | 8 | Antivirals |
| lenacapavir | 12 | 9 | Antivirals |
| lenalidomide | 68 | 13 | Immunosuppressants |
| lenvatinib | 49 | 14 | Antineoplastics |
| letermovir | 28 | 14 | Antivirals |
| letrozole | 10 | 4 | Endocrine therapy |
| levetiracetam | 33 | 6 | Antiepileptics |
| levodopa | 9 | 6 | Anti-parkinson |
| levonorgestrel | 25 | 5 | Sex hormones and modulators |
| linagliptin | 9 | 6 | Diabetes |
| liraglutide | 31 | 9 | Diabetes |
| lisdexamfetamine | 10 | 5 | Psychoanaleptics |
| lisocabtagene maraleucel | 27 | 11 | Antineoplastics |
| lixisenatide | 7 | 6 | Diabetes |
| lomitapide | 10 | 9 | Lipid modifying agents |
| loncastuximab tesirine | 8 | 8 | Antineoplastics |
| lopinavir / ritonavir | 14 | 5 | Antivirals |
| lorlatinib | 26 | 12 | Antineoplastics |
| lumasiran | 10 | 10 | Other alimentary tract and metabolism |
| lurasidone | 11 | 9 | Psycholeptics |
| luspatercept | 22 | 9 | Antianemics |
| maraviroc | 11 | 4 | Antivirals |
| maribavir | 15 | 14 | Antivirals |